Strs Ohio acquired a new stake in Nature's Sunshine Products, Inc. (NASDAQ:NATR - Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 29,900 shares of the company's stock, valued at approximately $375,000. Strs Ohio owned about 0.16% of Nature's Sunshine Products as of its most recent filing with the SEC.
Several other institutional investors have also recently bought and sold shares of the business. GAMMA Investing LLC raised its position in Nature's Sunshine Products by 2,090.2% in the 1st quarter. GAMMA Investing LLC now owns 2,234 shares of the company's stock valued at $28,000 after purchasing an additional 2,132 shares during the last quarter. Northern Trust Corp lifted its stake in shares of Nature's Sunshine Products by 2.7% during the fourth quarter. Northern Trust Corp now owns 119,005 shares of the company's stock valued at $1,745,000 after acquiring an additional 3,174 shares during the period. Bank of America Corp DE boosted its holdings in Nature's Sunshine Products by 12.2% in the fourth quarter. Bank of America Corp DE now owns 30,449 shares of the company's stock valued at $446,000 after acquiring an additional 3,312 shares during the last quarter. Deutsche Bank AG bought a new position in Nature's Sunshine Products in the fourth quarter valued at about $103,000. Finally, Skylands Capital LLC boosted its holdings in Nature's Sunshine Products by 1.7% in the first quarter. Skylands Capital LLC now owns 431,800 shares of the company's stock valued at $5,419,000 after acquiring an additional 7,209 shares during the last quarter. Institutional investors own 79.40% of the company's stock.
Insider Buying and Selling
In other Nature's Sunshine Products news, EVP Nathan G. Brower sold 9,996 shares of the business's stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $16.54, for a total value of $165,333.84. Following the completion of the transaction, the executive vice president directly owned 48,277 shares of the company's stock, valued at approximately $798,501.58. The trade was a 17.15% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Jonathan David Lanoy sold 5,000 shares of the business's stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $16.51, for a total value of $82,550.00. Following the completion of the transaction, the chief accounting officer directly owned 50,051 shares of the company's stock, valued at approximately $826,342.01. The trade was a 9.08% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 2,879,275 shares of company stock worth $33,123,599. Company insiders own 5.60% of the company's stock.
Nature's Sunshine Products Trading Up 2.8%
NASDAQ NATR opened at $16.62 on Tuesday. The stock has a 50-day simple moving average of $16.08 and a 200 day simple moving average of $14.48. The company has a market capitalization of $293.18 million, a PE ratio of 22.46 and a beta of 1.11. Nature's Sunshine Products, Inc. has a 12 month low of $11.01 and a 12 month high of $18.06.
Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $0.35 EPS for the quarter, beating analysts' consensus estimates of $0.16 by $0.19. The business had revenue of $114.75 million during the quarter, compared to the consensus estimate of $113.10 million. Nature's Sunshine Products had a return on equity of 10.19% and a net margin of 3.06%. Nature's Sunshine Products has set its FY 2025 guidance at EPS.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on NATR shares. DA Davidson reiterated a "buy" rating and issued a $19.00 price target on shares of Nature's Sunshine Products in a report on Tuesday, June 3rd. Canaccord Genuity Group raised their price target on Nature's Sunshine Products from $21.00 to $22.00 and gave the company a "buy" rating in a report on Friday, August 1st. Two analysts have rated the stock with a Buy rating, According to MarketBeat, Nature's Sunshine Products has a consensus rating of "Buy" and an average price target of $20.50.
View Our Latest Report on Nature's Sunshine Products
Nature's Sunshine Products Profile
(
Free Report)
Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nature's Sunshine Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nature's Sunshine Products wasn't on the list.
While Nature's Sunshine Products currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.